Healthcare provider profile · identity verified

John L Sager, MD

Family Practice · ASHLAND, OR · NPI 1306808043

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	367	108
Levothyroxine Sodium	Levothyroxine Sodium	265	69
Losartan Potassium	Losartan Potassium	218	63
Gabapentin	Gabapentin	170	40
Amlodipine Besylate	Amlodipine Besylate	157	47
Metoprolol Succinate	Metoprolol Succinate	149	44
Lisinopril	Lisinopril	139	46
Rosuvastatin Calcium	Rosuvastatin Calcium	123	32
Alendronate Sodium	Alendronate Sodium	104	24
Omeprazole	Omeprazole	101	30
Furosemide	Furosemide	89	25
Sertraline Hcl	Sertraline Hcl	89	21
Potassium Chloride	Potassium Chloride	87	21
Tamsulosin Hcl	Tamsulosin Hcl	85	29
Hydrochlorothiazide	Hydrochlorothiazide	82	21
Trazodone Hcl	Trazodone Hcl	74	21
Eliquis	Apixaban	68	13
Simvastatin	Simvastatin	67	21
Celecoxib	Celecoxib	66	20
Zolpidem Tartrate	Zolpidem Tartrate	62	19
Alprazolam	Alprazolam	60	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	16
Chlorthalidone	Chlorthalidone	52	15
Albuterol Sulfate Hfa	Albuterol Sulfate	50	26
Bupropion Xl	Bupropion Hcl	50	16
Lorazepam	Lorazepam	50	19
Meloxicam	Meloxicam	49	19
Donepezil Hcl	Donepezil Hcl	45	11
Valacyclovir	Valacyclovir Hcl	45	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	suppressed
Metformin Hcl	Metformin Hcl	42	16
Pravastatin Sodium	Pravastatin Sodium	40	14
Mirtazapine	Mirtazapine	39	11
Prednisone	Prednisone	39	30
Allopurinol	Allopurinol	38	14
Finasteride	Finasteride	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Estradiol	Estradiol	32	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	12
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Clonazepam	Clonazepam	30	suppressed
Carvedilol	Carvedilol	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	28	suppressed
Famotidine	Famotidine	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Azithromycin	Azithromycin	26	24
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Diazepam	Diazepam	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Xarelto	Rivaroxaban	18	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Atenolol	Atenolol	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Naproxen	Naproxen	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error